Researchers have announced the creation of what they claim may be the first synthetic cell, a breakthrough that has led to the establishment of a public benefit corporation aimed at sharing this technology with the broader scientific community. This development raises significant questions regarding the definition of life, as these synthetic cells exhibit cell-like properties yet differ fundamentally from natural cells.
Kate Adamala, an associate professor at the University of Minnesota and the leader of this research, explained that the team engineered a fully chemically defined cell-like system, eliminating unknown building blocks. This system is capable of performing functions previously thought exclusive to natural living cells, highlighting the potential for engineered biology to advance scientific understanding and applications.
Adamala’s team utilized lipid particles, known as liposomes, encapsulating DNA plasmids. These structures demonstrate the ability to divide and replicate their DNA, with 30% maintaining the original genetic code after five generations. However, they require specific enzymes and nutrients, delivered in liposomes, to sustain their functions. This innovation could have profound implications for various sectors within the pharmaceutical industry, including drug development and synthetic biology.
Get started today with Solo access →
